MetLife Investment Management’s Clearwater Analytics CWAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-152,700
Closed -$3.61M 2899
2026
Q1
$3.61M Sell
152,700
-1,295
-0.8% -$30.6K 0.02% 761
2025
Q4
$3.71M Buy
153,995
+9,273
+6% +$186K 0.02% 767
2025
Q3
$2.61M Sell
144,722
-2,651
-2% -$53.7K 0.01% 963
2025
Q2
$3.23M Buy
147,373
+38,356
+35% +$882K 0.02% 775
2025
Q1
$2.92M Buy
109,017
+1,495
+1% +$42K 0.02% 863
2024
Q4
$2.96M Buy
107,522
+21,096
+24% +$599K 0.02% 842
2024
Q3
$2.18M Buy
86,426
+51,022
+144% +$1.15M 0.01% 970
2024
Q2
$656K Buy
+35,404
New +$639K ﹤0.01% 1572

Other funds holding CWAN

MetLife Investment Management's CWAN Position: Q2 2026 in Review

MetLife Investment Management sold out of Clearwater Analytics (CWAN) in Q2 2026, closing a stake of 152,700 shares — an estimated $3.61M sold.

MetLife Investment Management first reported a position in CWAN in Q2 2024 and held it in 8 quarters. The position peaked at $3.71M in Q4 2025. 4 funds tracked by Wall St. Rank hold CWAN as of Q2 2026.

  • MetLife Investment Management reported no remaining Clearwater Analytics position as of Q2 2026 after selling out during the quarter.
  • MetLife Investment Management sold 152,700 Clearwater Analytics shares in Q2 2026, an estimated $3.61M.
  • MetLife Investment Management first reported a position in Clearwater Analytics in Q2 2024 and held it in 8 quarters.
  • MetLife Investment Management's Clearwater Analytics position peaked at $3.71M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Clearwater Analytics as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.